| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders … B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller, ... The World Journal of Biological Psychiatry 9 (4), 248-312, 2008 | 875 | 2008 |
| Epidemiological findings of seasonal changes in mood and behavior: a telephone survey of Montgomery County, Maryland. S Kasper, TA Wehr, JJ Bartko, PA Gaist, NE Rosenthal Archives of general psychiatry, 1989 | 820 | 1989 |
| Prevalence of seasonal affective disorder at four latitudes LN Rosen, SD Targum, M Terman, MJ Bryant, H Hoffman, SF Kasper, ... Psychiatry research 31 (2), 131-144, 1990 | 660 | 1990 |
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ... American Journal of Psychiatry 170 (11), 1249-1262, 2013 | 630 | 2013 |
| Social functioning in depression: a review RM Hirschfeld, SA Montgomery, MB Keller, S Kasper, AF Schatzberg, ... Journal of Clinical Psychiatry 61 (4), 268-275, 2000 | 594 | 2000 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: treatment of bipolar depression H Grunze, S Kasper, G Goodwin, C Bowden, D Baldwin, R Licht, E Vieta, ... The World Journal of Biological Psychiatry 3 (3), 115-124, 2002 | 572* | 2002 |
| CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages J Kirchheiner, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjöqvist, ... Acta Psychiatrica Scandinavica 104 (3), 173-192, 2001 | 538 | 2001 |
| Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study D Souery, P Oswald, I Massat, U Bailer, J Bollen, K Demyttenaere, ... The Journal of clinical psychiatry 68 (7), 2761, 2007 | 517 | 2007 |
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder GM Goodwin, CL Bowden, JR Calabrese, H Grunze, S Kasper, R White, ... The Journal of clinical psychiatry 65 (3), 14703, 2004 | 483 | 2004 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of … M Bauer, PC Whybrow, J Angst, M Versiani, HJ Moeller, ... The World Journal of Biological Psychiatry 3 (1), 5-43, 2002 | 447 | 2002 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar … H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Möller, ... Focus 9 (4), 500-525, 2011 | 446 | 2011 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of … H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Moeller, ... The World Journal of Biological Psychiatry 14 (3), 154-219, 2013 | 437 | 2013 |
| Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia S Kasper, MN Lerman, RD McQuade, A Saha, WH Carson, M Ali, ... International Journal of Neuropsychopharmacology 6 (4), 325-337, 2003 | 435 | 2003 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Moeller, ... The World Journal of Biological Psychiatry 10 (2), 85-116, 2009 | 412 | 2009 |
| Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference C Johansson, M Willeit, C Smedh, J Ekholm, T Paunio, T Kieseppä, ... Neuropsychopharmacology 28 (4), 734-739, 2003 | 401 | 2003 |
| Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder JP Olié, S Kasper The The International Journal of Neuropsychopharmacology 10 (5), 661-673, 2007 | 400 | 2007 |
| Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder A Hahn, P Stein, C Windischberger, A Weissenbacher, C Spindelegger, ... Neuroimage 56 (3), 881-889, 2011 | 399 | 2011 |
| Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care B Bandelow, L Sher, R Bunevicius, E Hollander, S Kasper, J Zohar, ... International journal of psychiatry in clinical practice 16 (2), 77-84, 2012 | 396 | 2012 |
| Application of transcranial magnetic stimulation in treatment of drug‐resistant major depression—a report of two cases G Höflich, S Kasper, A Hufnagel, S Ruhrmann, HJ Möller Human Psychopharmacology: Clinical and Experimental 8 (5), 361-365, 1993 | 372 | 1993 |
| Reduced serotonin-1A receptor binding in social anxiety disorder RR Lanzenberger, M Mitterhauser, C Spindelegger, W Wadsak, N Klein, ... Biological psychiatry 61 (9), 1081-1089, 2007 | 370 | 2007 |
Rupert LanzenbergerMedical University of ViennaVerified email at meduniwien.ac.at
